Early activity after strong sutures helps to tendon healing in a rat tendon rupture model by Chenfei Li, Jian Lu, Tianhao Guo, Xuyang Shi, Meng Fu, Yipeng Yang, Yanqing Zhou, Lingde Kong, Bing Zhang

“…The left Achilles tendon of 80 10-week-old rats was repaired. The rats were randomly divided into 4 groups: non-fixed group, fixed one week group, fixed two weeks group and fixed three weeks group. …”
Get full text

Monitoring Sleep and Nightly Recovery with Wrist-Worn Wearables: Links to Training Load and Performance Adaptations by Olli-Pekka Nuuttila, Daniela Schäfer Olstad, Kaisu Martinmäki, Arja Uusitalo, Heikki Kyröläinen

“…A total of 24 participants (10 females) performed a 3-week baseline training period (BL), a 2-week overload period (OL), and a 1-week recovery period (REC), which were followed by test days (T1–T3). …”
Get full text

Impact of health education on knowledge retention among caregivers of hypertensive patients: A prospective cross-sectional study in rural Malawi. by Chikondi Maluwa, Sitalire Kapira, Hataichanok Chuljerm, Wason Parklak, Kanokwan Kulprachakarn

“…Attitude improved from 16.76 (93.1%) at baseline to 17.74 (98.6%) at the six-week mark. Similarly, the mean practice score rose from 25.24 (78.9%) at baseline to 27.42 (85.7%) at week six. …”
Get full text

Comparisons of Differentiation Potential in Human Mesenchymal Stem Cells from Wharton’s Jelly, Bone Marrow, and Pancreatic Tissues by Shih-Yi Kao, Jia-Fwu Shyu, Hwai-Shi Wang, Chi-Hung Lin, Cheng-Hsi Su, Tien-Hua Chen, Zen-Chung Weng, Pei-Jiun Tsai

“…BM-IPCs reduced blood glucose levels at first week but gradually increased since week 3. In resected pancreas-IPCs group, blood glucose levels were significantly reduced till two weeks after transplantation and gradually increased since week 4. …”
Get full text

Glucose Metabolism of Human Prostate Cancer Mouse Xenografts by Hossein Jadvar, Xiankui Li, Antranik Shahinian, Ryan Park, Michel Tohme, Jacek Pinski, Peter S. Conti

“…Glucose metabolism was higher in the PC-3 tumor than in the CWR-22 tumor at both the 3-week (by 18%) and the 5-week (by 9.6%) micro-PET imaging sessions. …”
Get full text

Analyzing the Effect of Dancesport on Reducing Menopausal Symptoms and Increasing Quality of Life by Noortje Anita Kumaat, Soni Sulistyarto, Ratna Candra Dewi, Heri Wahyudi, Caturia Sasti Sulistyana, Nugroho Susanto, Ozgur Eken, Septyaningrum Putri Purwoto

“…The program involved a 12-week dance course, meeting twice a week for 60 minutes per session, including cha-cha, salsa, rumba, hip-hop, and waltz dances. …”
Get full text

Efektifitas Terapi Senam Stroke Terhadap Perbaikan Kemampuan Fungsional Pasien Paska Stroke by Neri Basmara, Reni Prima Gusty, Ema Julita

“…This study aimed to determine the difference in effectiveness of exercise therapy twice a week and three times a week in improving the functional abilities of stroke patients. …”
Get full text

Three Prospective Case Studies Examining Mifepristone’s Efficacy in Patients with Treatment-Resistant PTSD by Agnes van Minnen, Lizelotte Vos, Pierre M. Bet, Ad de Jongh, Felix Linsen, Hein J. F. van Marle, Onno C. Meijer, Willem M. Otte, Marije Russcher, Christiaan H. Vinkers

“…Three patients with PTSD who were resistant to standard psychological and pharmacological treatments were prescribed mifepristone (600–1,200 mg/day) for 1 week. A baseline-controlled single-case design was used, involving a 2-week baseline phase (no intervention), a 1-week intervention phase (mifepristone), and a 2-week postintervention phase. …”
Get full text

Walking for transport and all-cause mortality: a prospective cohort study of Australian community-dwelling older adults by Rory Wolfe, Neville Owen, Ben Beck, Yang Chen, David W Dunstan, Alice Owen, Robyn L Woods, Danijela Gasevic, Joanne Ryan, Shivangi Shah, Carlene Britt

“…Cox proportional-hazards models (HR and 95% CI) assessed the association between transport-related walking and all-cause mortality.Results Of participants, 44.1% reported walking every day, 31.5% more than once a week, 21.7% rarely or once a week and 2.7% never engaged in transport-related walking. …”
Get full text

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomat... by Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens

“…Randomized participants follow an 8-week dose escalation regimen (3 mg [weeks 0–4], 7 mg [weeks 4–8], and 14 mg [weeks 8–156]). …”
Get full text

Randomised controlled trial of topical kanuka honey for the treatment of rosacea by James Fingleton, Mark Weatherall, Richard Beasley, Irene Braithwaite, Janwillem Kocks, Mark Holliday, Andrew Corin, Colin Helm, Davitt Sheahan, Barney Montgomery, Judith Riley, Anna Hunt, Christopher Tofield

“…The change in IGA-RSS for Honevo compared to control at week 2 minus baseline was −1 (Hodges-Lehman estimate, 95% CI −1 to 0, p=0.03), and at week 8 minus baseline was −1 (Hodges-Lehman estimate, 95% CI −1 to 0, p=0.005). …”
Get full text

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension by Gerd R Burmester, Mark C Genovese, Vibeke Strand, Gregory St John, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Susan Boklage

“…Objective Evaluate open-label sarilumab monotherapy in patients with rheumatoid arthritis switching from adalimumab monotherapy in MONARCH (NCT02332590); assess long-term safety and efficacy in patients continuing sarilumab during open-label extension (OLE).Methods During the 48-week OLE, patients received sarilumab 200 mg subcutaneously once every 2 weeks. …”
Get full text

Blood glucose response to kratom tea (Mitragyna speciosa Korth.) by Fadly Dzul

“…Methods: This evaluation was executed using an experimental design with ten subjects, which included pure standard glucose in week 1 and standard glucose mixed with 1% kratom tea in week 2, with a 1-week wash-out period. …”
Get full text

Effect of Early Period of Postoperative Rehabilitation in Individuals with Transverse Patellar Fractures Treated by Tension Band with Kirschner by Zhongyi FANG, Shuai FAN, Xin JIANG, Lili XU, Likun LIU

“…Rehabilitation group received 2-week early postoperative exercise therapy, while the control group received postoperative education. …”
Get full text

Loss of Appetite in Adult Patients: Effectiveness and Safety of an Appetite Stimulating Medication in an Open-Label, Investigator-Initiated Study in India by S. Nagaraj

“…Majority of the patients had CNAQ appetite scores of 17–28 at baseline (94%), week 1 (66%), and week 2 (78%) of treatment. For patients with acute and chronic illness, a statistically significant improvement was observed in the mean CNAQ score at week 1 (26.75 (3.69), P = 0.0256; 25.24 (5.33), P = 0.0004) and at week 2 (26.63 (3.46), P = 0.0027; 25.26 (4.43), P ≤ 0.0001) from baseline (21.88 (3.31) and 22.12 (2.69), respectively). …”
Get full text

Effect of Motorized Elephant-Assisted Therapy Program on Balance Control of Children with Autism Spectrum Disorder by Satiansukpong Nuntanee, Sasat Daranee

“…Pretests were administered one week before participation in the METP, and then, posttests were administered one week after completing the METP. …”
Get full text

Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints by Stacy B. Menees, Anthony J. Lembo, William D. Chey

“…This multicenter, double-blind, placebo-controlled, parallel-group trial included adults with chronic idiopathic constipation randomized to polyethylene glycol 3350 17 g (n = 204) or placebo (n = 100) once daily for 24 weeks. Post hoc analyses were performed using the US Food and Drug Administration endpoint (≥3 complete spontaneous bowel movements/week and an increase of ≥1 complete spontaneous bowel movement/week from baseline for ≥9/12 weeks, including 3 of the last 4 weeks) along with additional efficacy and safety outcomes. …”
Get full text

Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report by Bassem Refaat, Adel Galal El-Shemi, Ahmed Mohamed Ashshi, Adnan AlZanbagi

“…This study was cross-sectional and sera were collected from 165 participants classified into 7 groups: 40 healthy negative control, 33 treatment naïve patients as positive control, 19 patients at week 4, 22 at week 12, and 19 at week 24 of treatment initiation and 21 responders and 11 nonresponders at the end of 48-week treatment protocol. …”
Get full text

The prognostic value of ferritinemia level in patients with chronic hepatitis C by N. C. Sargsyants, E. H. Grigoryan

“…The average level of ferritin in the patients included in PEGIFN α-2a and RBV group, prior to onset of treatment was normal (241,4±33,1), on the 12th week of treatment it turn to be elevated in 90% of patients with average level of 703,5±133,4 ng/dl (p=0,009 at comparison to initial level), and after the end of treatment course elevation was observed in 66,6% of patients at average value of 473,6±96,3 ng/dl (p=0,044 at to starting point, p=0,07 at comparison to the 12-th week data). …”
Get full text

Efficacy, safety, and tolerability of lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease by Namrata Sharma, Sayan Basu, Rohit Shetty, Pramod Kumar, Anindita Mondal, P Seshu Babu, Richa Srivastava, Ranjana A Pande, Shubashree Karat, Hemaxi P Desai, S Manjula, M Krishna Kumar

“…This trend was also maintained at week 12. Global improvement and tolerability were found to be better with lifitegrast than with CMC. …”
Get full text